Chronic Obstructive Pulmonary Disease Patients With Community-Acquired Pneumonia on Inhaled Corticosteroid Therapy: A Comprehensive Analysis of Risk Factors, Disease Burden, and Prevention Strategies.

According to our results, DM, HTN, inhaler duration, dyslipidemia, severity with vaccination of COVID‐19, and severity without vaccination of COVID‐19, for smoking histories from 15 to 20 pack years relative to smoking histories from 10 to 15 pack years, show highly significant results.

also in 132,142 other papers

The duration of ICS has a strong correlation with CAP in patients with a smoking history of 15–20 years; with shorter inhaler duration, CAP risk is not increased but rather shows a decreasing trend.

also in 47,180 other papers